A Dose Escalation Study to Assess Safety, Tolerability and Pharmacokinetics of ASP2409 Following a Single Intravenous Dose in Patients With Rheumatoid Arthritis on Methotrexate
Clinical trial NCT02171143 · COMPLETED
Trial details
- NCT number
- NCT02171143
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2014-04-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.